Nature Medicine | Spoonful of Medicine

Ahead of schedule, first hedgehog inhibitor drug gets the green light

In a landmark approval a month and half ahead of schedule, the first targeted treatment for basal cell carcinoma, the most common form of skin cancer, won approval today from the US Food and Drug Administration. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE